| Prev Close | 20.96 |
| Open | 20.96 |
| Day Low/High | 20.20 / 21.35 |
| 52 Wk Low/High | 20.59 / 178.85 |
| Volume | 1.32M |
| Avg Volume | 1.69M |
Tilray Inc. (TLRY)
20.66
0.30
1.43
NASDAQ : Process Industries
| Exchange | NASDAQ |
| Shares Outstanding | 80.98M |
| Market Cap | 2.02B |
| EPS | -0.80 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Tilray Foolishness
"The problem with the world is that fools and fanatics are always so certain of themselves and wiser people so full of doubts." -- Bertrand Russell The interest rate for a Tilray borrow is now over 264% -- that's annually! Be forewarned.
Tilray Surges Over 50% Wednesday Morning, Punishing Short-Sellers
The cannabis company has gained DEA approval to import a cannabinoid drug into the U.S.
Another Short-Selling Lesson (Part Deux)
* Tilray is now a sideshow of classic speculative activity * Neither go short nor go long TLRY * Ignore TLRY and move on Pot stock Tilray, Inc. is trading at $215/share (+$60 in premarket trading). The short squeeze is reminiscent of Robert Wilson'...
Experts Are High on Cannabis Stocks' 2019 Prospects
Expect more companies to join Coca-Cola, Molson Coors and Constellation Brands in checking out the market.
What's a Weary Market Bear to Do?
This is an ideal setup for a short squeeze.
FedEx's Report Was Soft, but the Guidance Isn't Bad
It is likely that value buyers will be looking for entry soon as the stock tests the $240 area.
Coke's Flirtation with Cannabis Reaffirms What We Already Know
The latest reports about Coke looking into cannabis confirms a broader industry trend.
Losing Trades Are a Sign of Superior Trading
If you don't have a steady diet of losing trades you probably aren't trading at optimal levels.
Bulletproof Market Shrugs Off the Negatives
Wild speculation in pot stocks and IPO names was a notable characteristic this week.
The Bullish Bias Resounds
This morning the futures (S&P and Nasdaq) are, as is the custom, higher. The markets continue to ignore a number of cautionary signposts/macroeconomic events/concerns and are benefiting from the float shrink of 5-7 years of corporate share buybacks,...
Tilray: The Trading Equivalent of a Ponzi Scheme
The pot stock is up some 500% even though probably everyone knows it's not worth that much.
Another Short Selling Lesson
Pot stock Tilray, Inc. is trading at $123/share (+$19 on the day). The short squeeze is reminiscent of Robert Wilson's legendary short in Resorts International. The price action in Resorts, Tilray, Tesla , etc., are examples of why my basic and firs...
Cannabis for Traders, Cannabis for Investors: Market Recon
Not every cannabis stock was strong on Wednesday. One significant Canadian name sure was though.
Vape Pen Growth Is Going to Explode
Here are 4 stocks to buy to invest in this trend.
Craft Your Buzz on Tilray
Tilray shares have more than tripled since the middle of August.
2 Big Themes Are Driving Chaotic Market Action
The underlying action, particularly the weakness in the technology sector, is reason for concern.
I Have No Interest in Facebook Right Now, but Twitter Is Intriguing
Facebook still needs to prove to the market that it can regain operational footing.
Will Investors Be Ready to Digest All the New Cannabis Stocks?
Several cannabis companies are planning to go public this fall.
Tilray Feeds Deal-Making Speculation on Analyst Call
Tilray reported a 95% jump in second-quarter revenue to $9.7 million, ahead of the Wall Street estimate of $9 million, in its first earnings release since it went public on July 19.
2 Trades on AMD's Incredible Run Higher: Market Recon
AMD continues to surge, after significant year-over-year improvements almost everywhere.
What If Canopy Growth Is Getting Too High?
This is simply a short-term thesis that the cannabis rally will cool this week.
Low Volume and Seasonality Is No Reason to Fight This Stock Market Uptrend
Seasonality hasn't mattered in a number or years so why should light volume new highs be an issue?
Tilray Offers Test of Transitioning to Recreational Cannabis Use in Canada
The Nasdaq-listed provider of medical marijuana will compete with other firms as Canada opens itself to general adult use of marijuana this fall.
Closing Bell: LIVE MARKETS BLOG
The company said that it has closed a $427 million funding round.
Why Pay a Premium for Estee Lauder?
EL's stock is up despite a guidance cut.
Cannabis Firm Tilray's Successful IPO Has Other Firms High on Going Public
Expect several more firms to list on stock exchanges this year.
Cannabis Specialist Acreage Eyes National Footprint as It Raises $119 Million
Acreage Holdings plans to publicly list common stock through a reverse merger on the Canadian Securities Exchange in the fall.
